Avience BiomedicalsNSE:AVIENCE 5 5-Year ROIIC % is 0.00 as of Mar. 2025. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100. Among 734 Medical Devices & Instruments companies, Avience Biomedicals ranks worse than 136239.65% on this metric.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Avience Biomedicals does not have enough data to calculate 5-Year ROIIC %.
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Avience Biomedicals 5-Year ROIIC % Related Terms
Avience Biomedicals 5-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Avience Biomedicals's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avience Biomedicals 5-Year ROIIC % Chart
Avience Biomedicals Annual Data
Trend
Mar23
Mar24
Mar25
5-Year ROIIC %
0.00
0.00
0.00
Avience Biomedicals Quarterly Data
Mar23
Mar24
Mar25
Jan26
5-Year ROIIC %
0.00
0.00
0.00
0.00
NSE:AVIENCE vs ABT, SYK, MDT: 5-Year ROIIC % Comparison
For the Medical Devices subindustry, Avience Biomedicals's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avience Biomedicals 5-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avience Biomedicals's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Avience Biomedicals's 5-Year ROIIC % falls into.
Avience Biomedicals's 5-Year ROIIC % for the quarter that ended in Mar. 2025 is calculated as:
5-Year ROIIC %
=
5-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
5-Year Incremental Invested Capital**
=
( 79.5102008 (Mar. 2025) - (Mar. 2020) )
/
( 433.503 (Mar. 2025) - (Mar. 2020) )
=
/
=
N/A%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Avience Biomedicals (NSE:AVIENCE) has a 5-Year ROIIC % of 0.00 as of Mar. 2025. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Avience Biomedicals and its competitors. According to the industry distribution chart, Avience Biomedicals ranks #999999 out of 734 companies in the Medical Devices & Instruments industry.
Is Avience Biomedicals' 5-Year ROIIC % too high?
Avience Biomedicals' current 5-Year ROIIC % is 0.00. Based on the distribution chart, Avience Biomedicals ranks #999999 out of 734 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' 5-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Avience Biomedicals ranks #999999 out of 734 companies for 5-Year ROIIC %. This places Avience Biomedicals in the lower half of its industry. The industry median 5-Year ROIIC % is 0.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Medical Devices & Instruments company?
The median 5-Year ROIIC % among Medical Devices & Instruments companies is 0.95, based on 734 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Avience Biomedicals and its competitors. For the Medical Devices & Instruments industry, the median 5-Year ROIIC % is 0.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avience Biomedicals's current 5-Year ROIIC % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current 5-Year ROIIC % of 0.00. The current 5-Year ROIIC % is 0.00. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current 5-Year ROIIC % is 0.00 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score
Get the complete analysis for NSE:AVIENCE
5-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AVIENCE has been successfully added to your 